APCRC-Q joins TRI's Official Opening celebrations
TRI is one of only a few facilities in the world to research, trial and manufacture breakthrough treatments all within the one location. APCRC-Q researchers were among the first to move into the new facility in December last year.
The Institute is a joint venture between four leading research institutes - the University of Queensland Diamantina Institute, the Queensland University of Technology's Institute of Health and Biomedical Innovation, Mater Research and the Princess Alexandra Hospital’s Centres for Health Research. A biopharmaceutical manufacturing facility has been co-located at TRI to enable the discovery, manufacture and testing of therapies and vaccines to improve and benefit the health of people world-wide.
Multi-disciplinary teams of doctors and researchers will work together at TRI to develop and test potential new treatments.
The opening of TRI marks a significant milestone in the history of medical research in Australia.
Watch APCRC-Q researchers talking about their experiences in the TRI Opening Video.
